Back

AI-derived myosteatosis on cardiac CT is associated with incident COPD risk: an AI-CVD study

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (2) - Cardiovascular risk assessment Imaging ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Morteza Naghavi

HeartLung.AI, Houston (United States of America)

7 More presentations in this session

Presentation thumbnail
Discussant - Cardiovascular risk assessment
Presentation thumbnail
Coronary artery calcium score and measures of prediabetes for cardiovascular risk prediction in patients referred for coronary CT angiography
Doctor K. Overgaard (Svendborg, DK)
Abstract Slides Video
Presentation thumbnail
Real-world cardiovascular risk assessment, and blood pressure and LDL-cholesterol control, by different medical specialties, during and post COVID-19 pandemia (SNAPSHOT studies Romania)
Doctor A. Ciobanu (Bucharest, RO)
Abstract Slides Video
Presentation thumbnail
Impact of HDL particle concentration on cardiovascular risk: a quantitative assessment using the PREVENT model
Doctor S. Hassan (San Diego, US)
Abstract Slides Video
Presentation thumbnail
The association of triglyceride-glucose index with coronary artery disease in patients who underwent coronary angiogram at a private tertiary hospital : a cross-sectional study
Doctor A. Dychiching (San Juan, PH)
Abstract Slides Video

Access the full session

Session thumbnail
New perspectives in cardiology (2) - Cardiovascular risk assessment

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Increased diagnostic testing and higher cardiovascular risk in patients with chronic obstructive pulmonary disease
thumbnail
Congress Presentation
Association between abdominal fat distribution, coronary artery calcium score, and all-cause mortality: data from a large cohort of patients submitted to cardiac CT scan
thumbnail
Congress Presentation
Combined effect of frailty and sarcopenia on the risk of cardiovascular disease: a longitude analysis in middle-aged and older adults

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources